Zobrazeno 1 - 10
of 17
pro vyhledávání: '"K.B. Bain"'
Autor:
K.B. Bain, Roger D. Yusen, Ramsey R. Hachem, K.A. Fester, Varun Puri, Patrick R. Aguilar, Thalachallour Mohanakumar, Hrishikesh S. Kulkarni, L.K. Tague, Chad A. Witt, Derek E. Byers, Elbert P. Trulock, Daniel Kreisel
Publikováno v:
Ann Am Thorac Soc
Rationale: Allosensitization may be a barrier to lung transplant. Currently, consideration is not given to allosensitization when assigning priority on the lung transplant waiting list. Objectives: We aimed to examine the association between allosens
Autor:
Derek E. Byers, K.A. Fester, Ramsey R. Hachem, Elbert P. Trulock, Chad A. Witt, K.B. Bain, Spenser E. January, Jennifer Alexander‐Brett, Hrishikesh S. Kulkarni
Publikováno v:
Clinical Transplantation. 33
BACKGROUND Chronic lung allograft dysfunction (CLAD) is the leading cause of death beyond the first year after lung transplantation. Several treatments have been used to prevent the progression or reverse the effects of CLAD. Cytolytic therapy with r
Autor:
K. Richardson, K. Bakos, Derek E. Byers, Ramsey R. Hachem, Daniel Kreisel, J. Iuppa, Chad A. Witt, Patrick R. Aguilar, Jennifer Alexander-Brett, Hrishikesh S. Kulkarni, Roger D. Yusen, K.B. Bain, K.A. Fester, Varun Puri, Elbert P. Trulock, B. Mittler
Publikováno v:
The Journal of Heart and Lung Transplantation. 38:S199-S200
Purpose CARV infections are associated with an increased risk of CLAD development and progression. Inhaled corticosteroids are used to treat airway inflammation , but there is a dearth of data regarding their use in lung transplantation . This study
Publikováno v:
The Journal of Heart and Lung Transplantation. 36:S61-S62
Autor:
K.B. Bain, Catherine Chen, Chad A. Witt, J. Iuppa, Derek E. Byers, G.A. Patterson, Elbert P. Trulock, Ramsey R. Hachem, Roger D. Yusen
Publikováno v:
Transplantation. 100(3)
Hyperammonemia is a rare, often fatal complication after transplantation. The etiology is unknown, but recognition and rapid treatment may help to improve the survival of this unusual syndrome. We present the largest case series to date of hyperammon
Publikováno v:
The Journal of Heart and Lung Transplantation. 36:S368
Autor:
T.A. Horwedel, K.A. Fester, J. Rago, Ramsey R. Hachem, K.B. Bain, Chad A. Witt, J.I. Melaragno
Publikováno v:
The Journal of Heart and Lung Transplantation. 36:S61
Publikováno v:
The Journal of Heart and Lung Transplantation. 36:S62
Publikováno v:
The Journal of Heart and Lung Transplantation. 35:S419
Publikováno v:
The Journal of Heart and Lung Transplantation. 32:S89-S90
Purpose Antibody mediated rejection (AMR) is a significant challenge after lung transplantation and no consensus exists on the optimal therapeutic approach. Bortezomib may serve as a treatment option by eradicating the antibody-producing plasma cells